These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6540568)

  • 21. Determination of doxycycline in human plasma and urine samples by high performance liquid chromatography. Application for drug monitoring in malaria chemoprophylaxis.
    Prévosto JM; Béraud B; Cheminel V; Gaillard Y; Mounier C; Chaulet JF
    Ann Biol Clin (Paris); 1995; 53(1-2):29-32. PubMed ID: 7574088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics and metabolism of sulfinpyrazone.
    Mahony C; Wolfram KM; Nash PV; Bjornsson TD
    Clin Pharmacol Ther; 1983 Apr; 33(4):491-7. PubMed ID: 6831828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid chromatographic determination of a new pyrazoloquinoline type benzodiazepine receptor antagonist and its hydroxy metabolite.
    Jedrychowski M; Schmidt EK; Bieck PR
    Arzneimittelforschung; 1988 Apr; 38(4):495-7. PubMed ID: 2840916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of the main metabolites of dipyrone by high-pressure liquid chromatography.
    Damm D
    Arzneimittelforschung; 1989 Nov; 39(11):1415-7. PubMed ID: 2619775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple and rapid high-performance liquid chromatographic method for the analysis of sulfinpyrazone and four of its metabolites in human plasma.
    Tam YK; Ferguson SM; Yau ML; Wyse DG
    J Chromatogr; 1984 Oct; 310(2):438-44. PubMed ID: 6511862
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative assay of sulphinpyrazone in plasma and urine by high-performance liquid chromatography.
    Lecaillon JB; Souppart C
    J Chromatogr; 1976 Jun; 121(2):227-34. PubMed ID: 932142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of sulfinpyrazone and its metabolites in human serum and in solutions of human serum albumin.
    Jakobsen P; Pedersen AK; Andreasen F
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):243-9. PubMed ID: 7136730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
    Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
    Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-performance liquid chromatographic analysis of the sulfide metabolite of sulfinpyrazone in plasma.
    Godbillon J; Gauron S; Gosset G
    J Chromatogr; 1982 Feb; 227(2):516-20. PubMed ID: 7061662
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of azobenzene and hydrazobenzene in phenylbutazone and sulfinpyrazone products by high-performance liquid chromatography.
    Matsui F; Lovering EG; Curran NM; Watson JR
    J Pharm Sci; 1983 Oct; 72(10):1223-4. PubMed ID: 6644580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment.
    Schlicht F; Staiger C; de Vries J; Gundert-Remy U; Hildebrandt R; Harenberg J; Wang NS; Weber E
    Eur J Clin Pharmacol; 1985; 28(1):97-103. PubMed ID: 3987792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of sulfinpyrazone and its metabolites in human plasma and urine by high-performance liquid chromatography.
    de Vries JX; Staiger C; Wang NS; Schlicht F
    J Chromatogr; 1983 Oct; 277():408-13. PubMed ID: 6643630
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of haloperidol and hydroxy haloperidol in human plasma by high performance liquid chromatography.
    Pommery J; Foulon O; Morineau G; Lhermitte M; Levron JC; Erb F
    Ann Biol Clin (Paris); 1990; 48(7):455-8. PubMed ID: 2278409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple and rapid micro-determination of sulfinpyrazone (Anturan) in biological fluids by reversed-phase high-performance liquid chromatography.
    Wong LT; Solomonraj G; Thomas BH
    J Chromatogr; 1978 Mar; 150(2):521-6. PubMed ID: 632338
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of malotilate and its metabolites in plasma and urine.
    Takasugi N; Mafune E; Yokokawa S; Toriyama K; Tsuchiya K; Sugimoto T
    J Chromatogr; 1985 Aug; 342(2):349-58. PubMed ID: 4055956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species differences in the disposition and metabolism of sulfinpyrazone.
    Dieterle W; Faigle JW
    Xenobiotica; 1981 Aug; 11(8):559-68. PubMed ID: 7303725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective and sensitive high-performance liquid chromatographic assay for the metabolites of nomifensine in human plasma.
    Lindberg RL
    J Chromatogr; 1985 Jun; 341(2):333-9. PubMed ID: 4030983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. Application to pharmacokinetics.
    Goebel KJ; Kölle EU
    J Chromatogr; 1985 Dec; 345(2):355-63. PubMed ID: 4086603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.
    Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG
    Br J Clin Pharmacol; 1982 Feb; 13(2):177-85. PubMed ID: 7059415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.